Research Directory

Oxford Capital Partners assesses the funding outlook

Read more

How Ablynx uses the llama to create antibodies

Read more

UK tightens law on biotech patents

Read more

Why tougher Biotech patents are welcomed

Read more

Commentary: Update on WARF stem cell patent application

Read more

Are patent backlogs creating an unequal playing field?

Read more

EMEA prepares for advanced therapies

Read more

Making sure that pharma's product pipelines are never empty

Read more

How first-in-man trials could be made safer

Read more

Medigene moves further into oncology

Read more